GlassScriptPhysician profile
Rosemary Lelich
NPI 1861809055
$2,904.30
in general payments reported to CMS, 2019-2025
10 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 95% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $175 · 2021: $217 · 2022: $80.45 · 2023: $402 · 2024: $105 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184 · Travel and Lodging: $915 · Education: $325 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.74 |
| Travel and Lodging | $914.76 |
| Education | $325.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,685.91 | 2025 | Invisalign |
| Zimmer Biomet Holdings, INC. | $262.13 | 2020-2021 | |
| Lightforce Orthodontics, INC. | $233.33 | 2023-2024 | |
| Dental Monitoring Sas | $202.33 | 2025 | |
| 3m Company | $159.04 | 2020-2022 | |
| Ormco Corporation | $146.14 | 2023 | Damon, Spark |
| Nobel Biocare USA | $73.06 | 2023 | Nobelactive |
| Solventum Corporation | $66.55 | 2024-2025 | Apc Flash-Free Clarity Advanced, 3m, Apc Flash-Free Victory Series Low Profile |
| American Orthodontics Corporation | $50.93 | 2021 | |
| Dentsply Sirona INC | $24.88 | 2024 | Astra Tech Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosemary Lelich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.